Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
Shazia Sofi, Umar Mehraj, Hina Qayoom, et al.
Medical Oncology (2022) Vol. 39, Iss. 9
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis
Hina Qayoom, Shazia Sofi, Manzoor Ahmad Mir
Immunologic Research (2023) Vol. 71, Iss. 4, pp. 588-599
Closed Access | Times Cited: 37
Molecular modeling and in vitro antiproliferative activity studies of some imidazole and isoxazole derivatives
Muhammed Tılahun Muhammed, Mustafa Er, Senem Akkoç
Journal of Molecular Structure (2023) Vol. 1282, pp. 135066-135066
Closed Access | Times Cited: 24
Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation
Shazia Sofi, Nusrat Jan, Hina Qayoom, et al.
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 9, pp. 103774-103774
Open Access | Times Cited: 23
Metronomic chemotherapy and drug repurposing: A paradigm shift in oncology
Nusrat Jan, Shazia Sofi, Hina Qayoom, et al.
Heliyon (2024) Vol. 10, Iss. 3, pp. e24670-e24670
Open Access | Times Cited: 9
Synthesis, characterization, and exploration of supramolecular assembly in a 4-aminophenazone derivative: A comprehensive study including hirshfeld surface analysis, computational investigation, and molecular docking
Muhammad Nawaz Tahir, Zahid Rashid, Khurram Shahzad Munawar, et al.
Journal of Molecular Structure (2024) Vol. 1308, pp. 137953-137953
Closed Access | Times Cited: 9
Hijacking and rewiring of host CircRNA/miRNA/mRNA competitive endogenous RNA (ceRNA) regulatory networks by oncoviruses during development of viral cancers
Mohammad Javad Kamali, Mohammad Salehi, Mehrnaz Mostafavi, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 2
Closed Access | Times Cited: 9
Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies
Doralyn S. Dalisay, Chuckcris P. Tenebro, Edna M. Sabido, et al.
Marine Drugs (2024) Vol. 22, Iss. 3, pp. 114-114
Open Access | Times Cited: 6
Cytochrome c and Cancer Cell Metabolism: A New Perspective
Asma Jan, Miss Shazia Sofi, Manzoor Ahmad Mir
Advances in Cancer Biology - Metastasis (2025), pp. 100134-100134
Open Access
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
Asma Jan, Shazia Sofi, Nusrat Jan, et al.
Future Oncology (2025), pp. 1-21
Closed Access
Mechanistic elucidation of Juglanthraquinone C targeting breast Cancer: A network Pharmacology-based investigation
Hina Qayoom, Mustfa Alkhanani, Abdullah Almilaibary, et al.
Saudi Journal of Biological Sciences (2023) Vol. 30, Iss. 7, pp. 103705-103705
Open Access | Times Cited: 19
Cytotoxic activities of the pyrimidine-based acetamide and isophthalimide derivatives: anin vitroandin silicostudies
Muhammed Tılahun Muhammed, Zülbiye Kökbudak, Senem Akkoç
Molecular Simulation (2023) Vol. 49, Iss. 10, pp. 982-992
Closed Access | Times Cited: 16
Unveiling the therapeutic potential of thymol from Nigella sativa L. seed: selective anticancer action against human breast cancer cells (MCF-7) through down-regulation of Cyclin D1 and proliferative cell nuclear antigen (PCNA) expressions
V. Vahitha, Growther Lali, Saradh Prasad, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Open Access | Times Cited: 5
Phyto-therapeutics as anti-cancer agents in breast cancer: Pathway targeting and mechanistic elucidation
Abdullah Almilaibary
Saudi Journal of Biological Sciences (2024) Vol. 31, Iss. 3, pp. 103935-103935
Open Access | Times Cited: 5
Cell cycle machinery in oncology: A comprehensive review of therapeutic targets
Simona Cavalu, A. M. Abdelhamid, Sameh Saber, et al.
The FASEB Journal (2024) Vol. 38, Iss. 11
Open Access | Times Cited: 4
Adapalene inhibits the growth of triple-negative breast cancer cells by S-phase arrest and potentiates the antitumor efficacy of GDC-0941
Umar Mehraj, Nissar Ahmad Wani, Abid Hamid, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 24
A comprehensive analysis of the role of molecular docking in the development of anticancer agents against the cell cycle CDK enzyme
PRIYANKA SOLANKI, Nisarg Rana, Prakash C. Jha, et al.
Biocell (2023) Vol. 47, Iss. 4, pp. 707-729
Open Access | Times Cited: 13
A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer
Hina Qayoom, Mustfa Alkhanani, Abdullah Almilaibary, et al.
Medical Oncology (2023) Vol. 40, Iss. 7
Closed Access | Times Cited: 13
Unveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning
Lu Zhao, Jian Wang, Wanchun Yang, et al.
Molecules (2024) Vol. 29, Iss. 11, pp. 2681-2681
Open Access | Times Cited: 4
Cyclin‐dependent kinases: Masters of the eukaryotic universe
Aleksandra J. Pluta, Cécilia Studniarek, Shona Murphy, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis
Burhan Ul Haq, Hina Qayoom, Shazia Sofi, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 3
Exploring Securigera securidaca Seeds as a Source of Potential CDK1 Inhibitors: Identification of Hippeastrine and Naringenin as Promising Hit Candidates
Mohamed E. M. Abdelbagi, Ghassab M. Al‐Mazaideh, Adil Elhag Ahmed, et al.
Processes (2023) Vol. 11, Iss. 5, pp. 1478-1478
Open Access | Times Cited: 9
Computational identification of potential inhibitors targeting cdk1 in colorectal cancer
Uchechukwu Chibuzo Ogbodo, Ojochenemi A. Enejoh, Chinelo H. Okonkwo, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 9
Cell Cycle Dysregulation in Breast Cancer
Manzoor Ahmad Mir, Sameer Ullah Khan, Shariqa Aisha
(2023), pp. 103-131
Closed Access | Times Cited: 8
A comprehensive analysis of notch signaling genes in breast cancer: Expression pattern and prognostic significance
Shazia Sofi, Hina Qayoom, Nusrat Jan, et al.
Advances in Cancer Biology - Metastasis (2023) Vol. 7, pp. 100104-100104
Open Access | Times Cited: 8
Improvement of variables interpretability in kernel PCA
Mitja Briscik, Marie‐Agnès Dillies, Sébastien Dejean
BMC Bioinformatics (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top